Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Molsen-David E"'
Autor:
Soares M; Centre for Health Economics, University of York, York, England, UK., Colson A; Department of Management Science, University of Strathclyde, Glasgow, Scotland, UK., Bojke L; Centre for Health Economics, University of York, York, England, UK., Ghabri S; Department of Medical Evaluation, HAS, Paris, France., Garay OU; Roche Diagnostics International AG, Rotkreuz, Switzerland., Felli JK; Eli Lilly and Company, Indianapolis, IN, USA., Lee K; Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada., Molsen-David E; ISPOR-Professional Society for Health Economics and Outcomes Research, Lawrenceville, NJ, USA., Morales-Napoles O; Delft University of Technology, Delft, The Netherlands., Shaffer VA; Department of Psychological Sciences, University of Missouri, Columbia, MO, USA., IJzerman MJ; University of Melbourne, School of Population and Global Health, Parkville, Australia; Erasmus School of Health Policy & Management, Rotterdam, The Netherlands. Electronic address: ijzerman@eshpm.eur.nl.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Nov; Vol. 27 (11), pp. 1469-1478.
Autor:
Schlichting M; Global Biostatistics, Epidemiology and Medical Writing, Merck KGaA, Darmstadt, Germany. Electronic address: michael.schlichting@merckgroup.com., Hennig M; Biostatistics and Epidemiology, Medical Department, GlaxoSmithKline GmbH & Co. KG, Munich, Germany., Rudell K; COA Science, Epidemiology and RW Science, Parexel, Chittering, England, UK., McLeod L; Patient-Centered Outcomes Assessment, RTI Health Solutions, Research Triangle Park, NC, USA., Bennett B; Patient-Reported Outcomes Assessment, Worldwide Health Economics and Outcomes Research, Bristol Myers Squibb Pharmaceuticals Limited, Uxbridge, England, UK., Shaw J; Patient-Reported Outcomes Research, Worldwide Health Economics and Outcomes Research, Bristol Myers Squibb, Princeton, NJ, USA., Doward L; Patient-Reported Outcomes, RTI Health Solutions, Manchester, England, UK., Molsen-David E; Scientific & Health Policy Initiatives, ISPOR, Lawrenceville, NJ, USA., Chassany O; Patient-Centered Outcomes Research, Université de Paris, Paris, France.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2022 Sep; Vol. 25 (9), pp. 1463-1468.
Autor:
Schuck, Stephane1 (AUTHOR) stephane.schuck@kappasante.com, Loussikian, Paul1 (AUTHOR), Mebarki, Adel1 (AUTHOR), Malaab, Joelle1 (AUTHOR), Foulquié, Pierre1 (AUTHOR), Talmatkadi, Manissa1 (AUTHOR), Kearney, Mairead2 (AUTHOR)
Publikováno v:
BMC Cancer. 11/25/2024, Vol. 24 Issue 1, p1-14. 14p.
Autor:
Marsh K; Evidera, London, England, UK. Electronic address: kevin.marsh@evidera.com., van Til JA; Health Technology and Services Research, University of Twente, Enschede, The Netherlands., Molsen-David E; Scientific and Health Policy Initiatives, ISPOR, Lawrenceville, NJ, USA., Juhnke C; Hochschule Neubrandenburg, Neubrandenburg, Germany., Hawken N; Modus Outcomes, Amsterdam, The Netherlands., Oehrlein EM; National Health Council, Washington, DC, USA., Choi YC; University of Minnesota College of Pharmacy, Minneapolis, Minnesota., Duenas A; ICN Business School, Nancy, France., Greiner W; Department of Health Economics, Bielefeld University, Bielefeld, Germany., Haas K; Cerenovus, New Brunswick, NJ, USA., Hiligsmann M; Department of Health Services Research, Maastricht University, Maastricht, The Netherlands., Hockley KS; Imperial Clinical Trials Unit, Imperial College London, London, England, UK., Ivlev I; Center for Health Research, Kaiser Permanente, Portland, OR, USA., Liu F; Merck & Co, Kenilworth, NJ, USA., Ostermann J; Department of Health Services Policy and Management, University of South Carolina, Columbia, SC, USA., Poder T; CIUSSS de l'Estrie-CHUS, Sherbrooke, QC, Canada., Poon JL; Eli Lilly and Company, Indianapolis, IN, USA., Muehlbacher A; Hochschule Neubrandenburg, Neubrandenburg, Germany; Department of Population Health Sciences, Duke University, Durham, NC, USA.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Jul; Vol. 23 (7), pp. 831-841. Date of Electronic Publication: 2020 Jul 05.
Autor:
Freijer K; School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands. Electronic address: k.freyer@maastrichtuniversity.nl., Volger S; Clinical Development Immunology Gastroenterology, Janssen R&D, Spring House, PA, USA., Pitter JG; Syreon Research Institute, Budapest, Hungary., Molsen-David E; Scientific & Health Policy Initiatives, ISPOR, Lawrenceville, NJ, USA., Cooblall C; Scientific & Health Policy Initiatives, ISPOR, Lawrenceville, NJ, USA., Evers S; School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands., Hiligsmann M; Department of Health Services Research of Maastricht University, Maastricht, Netherlands., Danel A; Nestle Health Science, Vevey, Switzerland., Lenoir-Wijnkoop I; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2019 Jan; Vol. 22 (1), pp. 1-12. Date of Electronic Publication: 2018 Oct 25.
Autor:
Santos J; Global Compliance and Quality Director, Kantar Health, Cambridge, Wales, UK., Palumbo F; Professor and Executive Director, Center on Drugs & Public Policy, University of Maryland School of Pharmacy, Bethesda, MD, USA. Electronic address: fpalumbo@rx.umaryland.edu., Molsen-David E; Director, Scientific & Health Policy Initiatives, ISPOR, Lawrenceville, NJ, USA., Willke RJ; Chief Science Officer, ISPOR, Lawrenceville, NJ, USA., Binder L; Health Policy Consultant, Save Your Skin Foundation, Toronto, ON, Canada., Drummond M; Co-Editor-in-Chief, Value in Health and Professor, Health Economics, Centre for Health Economics, University of York, Heslington, York, England, UK., Ho A; Associate Professor, Director of Undergraduate Medical Ethics Curriculum, Centre for Biomedical Ethics, National University of Singapore, Singapore., Marder WD; Chief Data Strategist, IBM Watson Health, Cambridge, MA, USA., Parmenter L; Vice President, Global Head Scientific Affairs, QuintilesIMS, Reading, England, UK., Sandhu G; Patient Engagement Specialist, Gurmit Sandhu Consulting GmbH, Basel, Switzerland., Shafie AA; Associate Professor, University Sains Malaysia, Member of National Good Governance of Medicine Policy and member of Ethics Board in Malaysia, Minden, Malaysia., Thompson D; Editor-in-Chief, Value & Outcomes Spotlight and Senior Vice President, Real World Evidence Advisory, INC Research / inVentiv Health, Boston, MA, USA.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2017 Dec; Vol. 20 (10), pp. 1227-1242. Date of Electronic Publication: 2017 Dec 06.
Autor:
Schoenen, Stefanie1 (AUTHOR), Verbeeck, Johan2 (AUTHOR), Koletzko, Lukas3 (AUTHOR), Brambilla, Isabella4,5 (AUTHOR), Kuchenbuch, Mathieu6,7 (AUTHOR), Dirani, Maya6,7 (AUTHOR), Zimmermann, Georg8 (AUTHOR), Dette, Holger3 (AUTHOR), Hilgers, Ralf-Dieter1 (AUTHOR) rhilgers@ukaachen.de, Molenberghs, Geert2,9 (AUTHOR), Nabbout, Rima6,7 (AUTHOR)
Publikováno v:
Orphanet Journal of Rare Diseases. 3/2/2024, Vol. 19 Issue 1, p1-13. 13p.
Autor:
Ng, Carrie-Anne, De Abreu Lourenco, Richard, Viney, Rosalie, Norman, Richard, King, Madeleine T, Kim, Nancy, Mulhern, Brendan
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research; Dec2024, Vol. 24 Issue 10, p1101-1114, 14p
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research; Nov2024, Vol. 24 Issue 9, p1053-1060, 8p
Publikováno v:
Healthcare (2227-9032); May2024, Vol. 12 Issue 10, p1041, 15p